This Program Announcement (PA) replaces PAR-03-124 ¹.

The NCI invites applications for the development and delivery of novel image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy, and which may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is primarily intended to facilitate the proof-of-feasibility, development, and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases, and, secondarily, to facilitate limited evaluation studies to show proof-of-concept and functionality.

• Release Date: April 19, 2004
• Application Receipt Date(s): February 1, June 1, and October 1
• Contacts: Guoying Liu, Ph.D. (liug@mail.nih.gov ²) at 301-594-5220
  Keyvan Farahani, Ph.D. (farahank@mail.nih.gov ³) at 301-451-2651
  James A. Deye, Ph.D. (deyej@mail.nih.gov ⁴) at 301-496-6276
  Houston Baker, Ph.D. (bakerhou@mail.nih.gov ⁵) at 301-594-9117
  

See full description in NIH Guide: PA-04-095 ⁶

What is the R21 grant mechanism? ⁷
What is the R33 grant mechanism? ⁷